BRCA2 and hepatocellular carcinoma: BRCA1, BRCA2, and ATR genes, along with their associated pathways, cyclins, and cell cycle regulation, as well as BRCA1-dependent Ub ligase activity, may contribute to the pathogenesis and progression of HCC, according to BioCarta [87].